352 related articles for article (PubMed ID: 17822495)
21. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
Tan ES; Tang MB; Tan SH
Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
[TBL] [Abstract][Full Text] [Related]
22. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
[TBL] [Abstract][Full Text] [Related]
23. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
24. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
[TBL] [Abstract][Full Text] [Related]
25. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
26. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
27. The head and neck manifestations of mycosis fungoides.
Brennan JA
Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661
[TBL] [Abstract][Full Text] [Related]
28. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
[TBL] [Abstract][Full Text] [Related]
29. Central nervous system involvement in patients with mycosis fungoides and cutaneous large-cell transformation.
Vu BA; Duvic M
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S16-22. PubMed ID: 18625371
[TBL] [Abstract][Full Text] [Related]
30. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis.
Belousova IE; Vanecek T; Samtsov AV; Michal M; Kazakov DV
J Am Acad Dermatol; 2008 Sep; 59(3):474-82. PubMed ID: 18694680
[TBL] [Abstract][Full Text] [Related]
31. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
32. Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients.
Piccinno R; Caccialanza M; Percivalle S
J Dermatolog Treat; 2009; 20(3):165-8. PubMed ID: 18979277
[TBL] [Abstract][Full Text] [Related]
33. Early-stage mycosis fungoides, parapsoriasis en plaque, and pregnancy.
Amitay-Layish I; David M; Kafri B; Barzilai A; Feinmesser M; Hodak E
Int J Dermatol; 2007 Feb; 46(2):160-5. PubMed ID: 17269968
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
35. Unilesional follicular mycosis fungoides: report of two cases with progression to tumor stage and review of the literature.
Kempf W; Kazakov DV; Schermesser M; Buechner SA; Parmentier L; Wysocki A; Palmedo G; Häusermann P
J Cutan Pathol; 2012 Sep; 39(9):853-60. PubMed ID: 22882174
[TBL] [Abstract][Full Text] [Related]
36. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
[TBL] [Abstract][Full Text] [Related]
37. Frequency and prognostic significance of clonal T-cell receptor beta-gene rearrangements in the peripheral blood of patients with mycosis fungoides.
Bakels V; van Oostveen JW; Gordijn RL; Walboomers JM; Meijer CJ; Willemze R
Arch Dermatol; 1992 Dec; 128(12):1602-7. PubMed ID: 1456753
[TBL] [Abstract][Full Text] [Related]
38. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
[TBL] [Abstract][Full Text] [Related]
39. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
40. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]